IN2014DN00123A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN00123A IN2014DN00123A IN123DEN2014A IN2014DN00123A IN 2014DN00123 A IN2014DN00123 A IN 2014DN00123A IN 123DEN2014 A IN123DEN2014 A IN 123DEN2014A IN 2014DN00123 A IN2014DN00123 A IN 2014DN00123A
- Authority
- IN
- India
- Prior art keywords
- compounds
- mek
- inflammation
- inhibitors
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN123DEN2014 IN2014DN00123A (es) | 2011-06-09 | 2012-06-06 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1634DE2011 | 2011-06-09 | ||
CN201210175145 | 2012-05-31 | ||
IN123DEN2014 IN2014DN00123A (es) | 2011-06-09 | 2012-06-06 | |
PCT/IB2012/052860 WO2012168884A1 (en) | 2011-06-09 | 2012-06-06 | Heterocyclic sulfonamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN00123A true IN2014DN00123A (es) | 2015-05-22 |
Family
ID=46384435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN123DEN2014 IN2014DN00123A (es) | 2011-06-09 | 2012-06-06 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2718276A1 (es) |
JP (1) | JP2014517004A (es) |
KR (1) | KR20140034898A (es) |
AU (1) | AU2012265844A1 (es) |
BR (1) | BR112013031201A2 (es) |
CA (1) | CA2838029A1 (es) |
EA (1) | EA201391820A1 (es) |
IN (1) | IN2014DN00123A (es) |
MX (1) | MX2013014398A (es) |
WO (1) | WO2012168884A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104011039A (zh) * | 2011-12-19 | 2014-08-27 | 住友化学株式会社 | 磺酸盐的制造方法 |
EP3251673A1 (en) | 2012-12-13 | 2017-12-06 | IP Gesellschaft für Management mbH | Combination therapy comprising a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer |
CN104886052B (zh) * | 2015-06-02 | 2016-08-31 | 吉林省八达农药有限公司 | 一种环丙磺酰胺的应用 |
WO2018218071A1 (en) * | 2017-05-25 | 2018-11-29 | Araxes Pharma Llc | Compounds and methods of use thereof for treatment of cancer |
WO2019183385A1 (en) * | 2018-03-22 | 2019-09-26 | University Of Rochester | Mapk/erk inhibition for ovarian and other cancers |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR901228A (fr) | 1943-01-16 | 1945-07-20 | Deutsche Edelstahlwerke Ag | Système d'aimant à entrefer annulaire |
GB1524747A (en) | 1976-05-11 | 1978-09-13 | Ici Ltd | Polypeptide |
ATE28864T1 (de) | 1982-07-23 | 1987-08-15 | Ici Plc | Amide-derivate. |
GB8327256D0 (en) | 1983-10-12 | 1983-11-16 | Ici Plc | Steroid derivatives |
US5093330A (en) | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
US5010099A (en) | 1989-08-11 | 1991-04-23 | Harbor Branch Oceanographic Institution, Inc. | Discodermolide compounds, compositions containing same and method of preparation and use |
US5395855A (en) | 1990-05-07 | 1995-03-07 | Ciba-Geigy Corporation | Hydrazones |
NZ243082A (en) | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
GB9300059D0 (en) | 1992-01-20 | 1993-03-03 | Zeneca Ltd | Quinazoline derivatives |
TW225528B (es) | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
ATE348110T1 (de) | 1992-10-28 | 2007-01-15 | Genentech Inc | Hvegf rezeptor als vegf antagonist |
GB9314893D0 (en) | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
EP0817775B1 (en) | 1995-03-30 | 2001-09-12 | Pfizer Inc. | Quinazoline derivatives |
GB9508538D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
US5880141A (en) | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
US5843901A (en) | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
MX9800215A (es) | 1995-07-06 | 1998-03-31 | Novartis Ag | Pirrolopirimidas y procesos para su preparacion. |
US5760041A (en) | 1996-02-05 | 1998-06-02 | American Cyanamid Company | 4-aminoquinazoline EGFR Inhibitors |
GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
DE69710712T3 (de) | 1996-04-12 | 2010-12-23 | Warner-Lambert Co. Llc | Umkehrbare inhibitoren von tyrosin kinasen |
CA2258548C (en) | 1996-06-24 | 2005-07-26 | Pfizer Inc. | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases |
WO1998008849A1 (de) | 1996-08-30 | 1998-03-05 | Novartis Aktiengesellschaft | Verfahren zur herstellung von epothilonen und zwischenprodukte innerhalb des verfahrens |
AU4141697A (en) | 1996-09-06 | 1998-03-26 | Obducat Ab | Method for anisotropic etching of structures in conducting materials |
DE19638745C2 (de) | 1996-09-11 | 2001-05-10 | Schering Ag | Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) |
AU4342997A (en) | 1996-09-13 | 1998-04-02 | Sugen, Inc. | Use of quinazoline derivatives for the manufacture of a medicament in the reatment of hyperproliferative skin disorders |
EP0837063A1 (en) | 1996-10-17 | 1998-04-22 | Pfizer Inc. | 4-Aminoquinazoline derivatives |
EP1367057B1 (de) | 1996-11-18 | 2008-09-17 | Gesellschaft für biotechnologische Forschung mbH (GBF) | Epothilone E und F |
US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
CO4950519A1 (es) | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
CO4940418A1 (es) | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
GB9721069D0 (en) | 1997-10-03 | 1997-12-03 | Pharmacia & Upjohn Spa | Polymeric derivatives of camptothecin |
US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
EP1058679B1 (en) | 1998-02-25 | 2005-10-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues therof |
EP1107964B8 (en) | 1998-08-11 | 2010-04-07 | Novartis AG | Isoquinoline derivatives with angiogenesis inhibiting activity |
GB9824579D0 (en) | 1998-11-10 | 1999-01-06 | Novartis Ag | Organic compounds |
UA71587C2 (uk) | 1998-11-10 | 2004-12-15 | Шерінг Акцієнгезелльшафт | Аміди антранілової кислоти та їхнє застосування як лікарських засобів |
KR100851418B1 (ko) | 1998-11-20 | 2008-08-08 | 코산 바이오사이언시즈, 인코포레이티드 | 에포틸론 및 에포틸론 유도체의 생산을 위한 재조합 방법 및 물질 |
DE69926536T3 (de) | 1998-12-22 | 2013-09-12 | Genentech, Inc. | Antagonisten von vaskular-endothelialen zellwachstumsfaktoren und ihre anwendung |
ES2265929T3 (es) | 1999-03-30 | 2007-03-01 | Novartis Ag | Derivados de ftalazina para el tratamiento de enfermedades inflamatorias. |
PE20020354A1 (es) | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
TWI238824B (en) | 2001-05-14 | 2005-09-01 | Novartis Ag | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives |
GB0119249D0 (en) | 2001-08-07 | 2001-10-03 | Novartis Ag | Organic compounds |
JP2006083137A (ja) * | 2004-09-17 | 2006-03-30 | Sankyo Co Ltd | 免疫抑制剤 |
JP5491199B2 (ja) * | 2007-01-19 | 2014-05-14 | アルデア バイオサイエンシズ,インコーポレイティド | Mekのインヒビター |
EP2175885B1 (en) * | 2007-07-30 | 2016-10-12 | Ardea Biosciences, Inc. | Combinations of mek inhibitors and raf kinase inhibitors and uses thereof |
US20110098288A1 (en) * | 2008-03-11 | 2011-04-28 | Jeremy Major | Sulfonamides as zap-70 inhibitors |
EP2310373A1 (en) * | 2008-07-01 | 2011-04-20 | Genentech, Inc. | Bicyclic heterocycles as mek kinase inhibitors |
KR20120028882A (ko) * | 2009-04-21 | 2012-03-23 | 노파르티스 아게 | Mek 억제제로서의 헤테로시클릭 화합물 |
CN102134218A (zh) * | 2009-06-15 | 2011-07-27 | 凯美隆(北京)药业技术有限公司 | 6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂 |
CN102596951B (zh) * | 2009-11-04 | 2015-04-15 | 诺华股份有限公司 | 用作mek抑制剂的杂环磺酰胺衍生物 |
GEP20135998B (en) * | 2009-12-08 | 2013-12-25 | Novartis Ag | Heterocyclic sulfonamide derivatives |
-
2012
- 2012-06-06 CA CA2838029A patent/CA2838029A1/en not_active Abandoned
- 2012-06-06 WO PCT/IB2012/052860 patent/WO2012168884A1/en active Application Filing
- 2012-06-06 KR KR1020147000283A patent/KR20140034898A/ko not_active Application Discontinuation
- 2012-06-06 IN IN123DEN2014 patent/IN2014DN00123A/en unknown
- 2012-06-06 AU AU2012265844A patent/AU2012265844A1/en not_active Abandoned
- 2012-06-06 BR BR112013031201A patent/BR112013031201A2/pt not_active IP Right Cessation
- 2012-06-06 JP JP2014514204A patent/JP2014517004A/ja active Pending
- 2012-06-06 EA EA201391820A patent/EA201391820A1/ru unknown
- 2012-06-06 EP EP12730043.2A patent/EP2718276A1/en not_active Withdrawn
- 2012-06-06 MX MX2013014398A patent/MX2013014398A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2718276A1 (en) | 2014-04-16 |
AU2012265844A1 (en) | 2013-05-02 |
BR112013031201A2 (pt) | 2017-01-31 |
JP2014517004A (ja) | 2014-07-17 |
EA201391820A1 (ru) | 2014-12-30 |
KR20140034898A (ko) | 2014-03-20 |
MX2013014398A (es) | 2014-03-21 |
CA2838029A1 (en) | 2012-12-13 |
WO2012168884A1 (en) | 2012-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014028600A3 (en) | 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | |
AU2012214029A8 (en) | Rorgammat inhibitors | |
IN2015DN01156A (es) | ||
PH12014501561A1 (en) | Therapeutically active compounds and their methods of use | |
IN2014KN00769A (es) | ||
CR20200479A (es) | COMPUESTOS TERAPÉUTICAMENTE ACTIVOS Y SUS MÉTODOS DE USO (Divisional 2016-0069) | |
MX2011011083A (es) | Compuestos heterociclicos como inhibidores de mek. | |
TN2012000465A1 (en) | Derivatives of 1-amino-2-cyclopropylethylboronic acid | |
IN2014MN00948A (es) | ||
MX349159B (es) | Derivados deuterados de ivacaftor. | |
EP2750694B8 (en) | Methods and compositions relating to p62 for the treatment and prophylaxis of cancer | |
IN2014MN00987A (es) | ||
IN2015DN01119A (es) | ||
PH12014501829A1 (en) | Bicyclic pyrazinone derivatives | |
MX348726B (es) | Inhibición del il17 e ifn-gamma para el tratamiento de inflamación autoinmune. | |
MX353762B (es) | Inhibicion de il17 e ifn-gamma para el tratamiento de inflamacion autoinmune. | |
WO2015003355A3 (en) | Therapeutically active compounds and their methods of use | |
MX345127B (es) | Derivados de tiazol. | |
MX2014003376A (es) | Derivados de acido benzoico como inhibidores eif4e. | |
EA032271B9 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
IN2014DN00123A (es) | ||
TN2012000242A1 (en) | Heterocyclic sulfonamide derivatives | |
MX2015007945A (es) | Usos y métodos para el tratamiento de enfermedades o afecciones hepáticas. | |
IN2014DN03010A (es) | ||
MX348147B (es) | Biarilsulfonamidas utiles en el tratamiento de la inflamacion y cancer. |